Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids
| dc.contributor.author | Middelkoop, Mei An | |
| dc.contributor.author | De Lange, Maria E. | |
| dc.contributor.author | Clark, T. Justin | |
| dc.contributor.author | Mol, Ben Willem J. | |
| dc.contributor.author | Bet, Pierre M. | |
| dc.contributor.author | Huirne, Judith A.F. | |
| dc.contributor.author | Hehenkamp, Wouter J.K. | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2023-03-31T08:54:01Z | |
| dc.date.available | 2023-03-31T08:54:01Z | |
| dc.date.issued | 2022-05-01 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 455837 | |
| dc.identifier | 229267778 | |
| dc.identifier | 7085e9d7-79df-4e1e-ab5a-62b35bfebdf9 | |
| dc.identifier | 85129998224 | |
| dc.identifier | 35143669 | |
| dc.identifier.citation | Middelkoop, M A, De Lange, M E, Clark, T J, Mol, B W J, Bet, P M, Huirne, J A F & Hehenkamp, W J K 2022, 'Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids', Human Reproduction, vol. 37, no. 5, pp. 884-894. https://doi.org/10.1093/humrep/deac009 | en |
| dc.identifier.doi | 10.1093/humrep/deac009 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 0268-1161 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20386 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85129998224&partnerID=8YFLogxK | en |
| dc.identifier.vol | 37 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Human Reproduction | en |
| dc.subject | clinical trials | en |
| dc.subject | leiomyoma | en |
| dc.subject | Phase III | en |
| dc.subject | randomized controlled trials | en |
| dc.subject | risk evaluation and mitigation | en |
| dc.subject | ulipristal acetate | en |
| dc.subject | R Medicine | en |
| dc.subject | Reproductive Medicine | en |
| dc.subject | Obstetrics and Gynaecology | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Middelkoop_etal_HR_Evaluation_Of_Marketing_VoR.pdf
- Size:
- 445.15 KB
- Format:
- Adobe Portable Document Format
